Remrise is a technology company.
Remrise has raised $8.0M across 1 funding round.
Remrise has raised $8.0M in total across 1 funding round.
Remrise has raised $8.0M in total across 1 funding round.
Remrise's investors include Abstract Ventures, Alumni Ventures, AME Cloud Ventures, Andreessen Horowitz, Atomic, DFJ Growth, DST Global, General Catalyst, Hardware Club, Khosla Ventures, LGF, Menlo Ventures.
Remrise is a San Francisco–based sleep-health company that builds personalized, plant‑powered sleep supplements and digital tools designed to improve sleep without melatonin or prescription drugs.[1][4]
High-Level Overview
Remrise’s mission is to improve sleep quality through personalized, holistic, plant‑based formulations and behavioral tools that blend Eastern and Western herbal traditions with modern product design.[3][4]
Its investment backing includes seed investors such as Atomic Management, Founders Fund, Felicis, Maverick Capital and Signia Venture Partners, reflecting venture interest in consumer health and wellness brands scaling direct‑to‑consumer and retail channels[1][4].
Remrise focuses on the sleep‑health and wellness sector, targeting consumers who prefer natural, non‑melatonin alternatives for falling and staying asleep; it also sells through premium retail and online channels.[1][3]
The company’s impact on the startup ecosystem is as a category‑definer in plant‑first sleep aids—helping legitimize a subsegment of sleep wellness that combines personalized product recommendations, natural ingredients, and lifestyle support tools that other startups and incumbents have begun to emulate.[1][3][4]
Origin Story
Remrise was founded in 2018 and is headquartered in San Francisco.[1]
The company was built by founders who combined backgrounds in consumer product design and health‑tech (public reporting highlights founders with experience in wellness and consumer brands), and the idea emerged from the market gap for non‑melatonin, evidence‑informed sleep solutions that integrate herbal traditions with personalized regimens.[3][4]
Early traction included launch press, placement on premium retail platforms (including being noted as a melatonin‑free sleep aid sold on notable lifestyle channels) and a seed financing round raising about $8.2 million to scale product development and distribution.[1][3][4]
Core Differentiators
Role in the Broader Tech Landscape
Remrise rides the larger trends of personalized health, consumerization of wellness, and preference for natural alternatives to pharmaceutical sleep aids—markets that have expanded as users seek long‑term sleep solutions and prevention‑oriented care.[2][3]
Timing matters because consumer awareness of sleep’s impact on health has grown, retail channels for wellness products have matured, and investors are allocating capital to digitally enabled consumer health brands that can scale both online and in stores.[2][4]
Market forces working in Remrise’s favor include a large and growing sleep‑health market (estimated in industry coverage as a multibillion‑dollar opportunity), rising demand for non‑habit‑forming solutions, and retail partnerships that accelerate consumer trial and visibility.[2][4]
By legitimizing plant‑first, personalized sleep supplements, Remrise influences competitors and new entrants to prioritize ingredient transparency, personalization, and lifestyle support tools alongside product sales.[1][3]
Quick Take & Future Outlook
Next steps for Remrise likely include expanding product SKUs and personalization capabilities, deepening digital tools for longitudinal sleep improvement, and scaling retail distribution and partnerships to accelerate customer acquisition and repeat purchase.[4][3]
Trends that will shape its journey include continued consumer interest in non‑pharmaceutical sleep aids, regulatory attention on supplement claims (which will favor clinically rigorous ingredient storytelling), and the growing integration of digital health data into personalized consumer products.[3][4]
If Remrise sustains product efficacy, improves personalization, and leverages its retail + DTC mix, it can solidify a leadership position in the plant‑based sleep category and influence how mainstream brands approach non‑drug sleep solutions.[1][4]
If you’d like, I can: summarize Remrise’s product lineup and ingredients in a one‑page brief, map its retail and investor network, or create a short investor‑style SWOT based on reported data.[1][3][4]
Remrise has raised $8.0M across 1 funding round. Most recently, it raised $8.0M Seed in November 2019.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Nov 1, 2019 | $8.0M Seed | Abstract Ventures, Alumni Ventures, AME Cloud Ventures, Andreessen Horowitz, Atomic, DFJ Growth, DST Global, General Catalyst, Hardware Club, Khosla Ventures, LGF, Menlo Ventures, Quiet Capital, Sherpalo Ventures, SNR, Y Combinator, ZhenFund, Claire Hughes Johnson, Eric Ries, Jeffrey Lee, Marc Benioff, Othman Laraki, Scott Belsky |